ArticleTherapeutic advances in hematology2023

Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysis.

Jae-Ho Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.